Programme & Benefits
The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening. There are major problems with current drug discovery:
- Genomic and high-throughput technologies are driving the volume of new drug leads, but despite this volume, the number of successes has remained static; there is a productivity crisis.
- Overly simple in vitro screens and non-human animal models are not predicting fails and so 40% of new drug fails are discovered during human trials.
The lifETIME CDT thus focuses on development of non-animal technologies to improve predictive power of pre-clinical drug screens and thus drive medicines discovery.
Equality, Diversity and Inclusion
LifETIME have placed EDI at the heart of its activities offering part-time studentships, childcare support for conference attendance, flexible working for careers as well as prompting work-life balance.
We offer EDI funding to support applications from widening participation backgrounds and for those who require additional EDI support. We can provide additional funding of £2k p.a.
How to Apply
LifETIME CDT UK Universities
(Glasgow, Birmingham and Aston)
Applications for all UK Universities must be submitted through the University of Glasgow online system for session 2022/23. Application deadline is 31st January 2022.
LifETIME CDT CÚRAM
Applications for CÚRAM must be submitted through NUI Galway online system for session 2022/23. Application deadline is 31st January 2022.